Scientia Ventures™ invests in early to mid-stage technology companies that target computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. Our strength is working with entrepreneurs and big ideas to build companies with the potential to transform healthcare. Our Partners have a long history of working together, many of whom are former founders, operators or CEO’s of important healthcare companies and who have domain expertise across healthcare, finance and intellectual property.
People
- Rory Riggs, General Partner
You last contacted this investor on .